NASDAQ (usa) | 6715.56 | -12.11 | -0.18% | |
FTSE 100 (london) | 7487.96 | -5.12 | -0.07% | |
DAX (german) | 13465.51 | 235.94 | 1.78% | |
NIKKEI 225 (japan) | 22420.08 | 408.47 | 1.86% | |
Hang - Seng (hong kong) | 28594.06 | 348.52 | 1.23% |
NIFTY - 50 (india) | ||||
Straits Times (singapore) | 3391.61 | 17.53 | 0.52% | |
KOSPI (korea) | 2556.47 | 33.04 | 1.31% | |
All Ordinaries (australia) | 6005.30 | 28.90 | 0.48% | |
BOVESPA (brazil) | 74092.76 | -215.73 | -0.29% |
Profound Medical Corp (NASDAQ: PROF)
PROF Technical Analysis
5
As on 9th Jun 2023 PROF STOCK Price closed @ 14.86 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 7.61 & Strong Buy for SHORT-TERM with Stoploss of 10.12 we also expect STOCK to react on Following IMPORTANT LEVELS. |
PROFSTOCK Price
Open | 14.82 | Change | Price | % |
High | 15.03 | 1 Day | 0.04 | 0.27 |
Low | 14.67 | 1 Week | 2.81 | 23.32 |
Close | 14.86 | 1 Month | 3.08 | 26.15 |
Volume | 29300 | 1 Year | 4.17 | 39.01 |
52 Week High 14.88 | 52 Week Low 3.18 |
NASDAQ USA Most Active Stocks
TSLA | 244.40 | 4.06% |
TTOO | 0.07 | -12.50% |
SOFI | 8.18 | 0.74% |
FFIE | 0.33 | 6.45% |
PONO | 1.72 | 2.38% |
AMD | 124.92 | 3.20% |
IDEX | 0.06 | 0.00% |
NKLA | 0.70 | 14.75% |
AMZN | 123.43 | -0.66% |
AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
PROF Daily Charts |
PROF Intraday Charts |
Whats New @ Bazaartrend |
PROF Free Analysis |
|
PROF Important Levels Intraday
RESISTANCE | 15.55 |
RESISTANCE | 15.33 |
RESISTANCE | 15.19 |
RESISTANCE | 15.06 |
SUPPORT | 14.66 |
SUPPORT | 14.53 |
SUPPORT | 14.39 |
SUPPORT | 14.17 |
PROF Forecast May 2024
4th UP Forecast | 19.97 |
3rd UP Forecast | 18.33 |
2nd UP Forecast | 17.32 |
1st UP Forecast | 16.3 |
1st DOWN Forecast | 13.42 |
2nd DOWN Forecast | 12.4 |
3rd DOWN Forecast | 11.39 |
4th DOWN Forecast | 9.75 |
PROF Weekly Forecast
4th UP Forecast | 17.13 |
3rd UP Forecast | 16.40 |
2nd UP Forecast | 15.95 |
1st UP Forecast | 15.50 |
1st DOWN Forecast | 14.22 |
2nd DOWN Forecast | 13.77 |
3rd DOWN Forecast | 13.32 |
4th DOWN Forecast | 12.59 |
PROF Forecast2024
4th UP Forecast | 37.96 |
3rd UP Forecast | 30.55 |
2nd UP Forecast | 25.97 |
1st UP Forecast | 21.39 |
1st DOWN Forecast | 8.33 |
2nd DOWN Forecast | 3.75 |
3rd DOWN Forecast | -0.83 |
4th DOWN Forecast | -8.24 |
Profound Medical Corp ( NASDAQ USA Symbol : PROF )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
PROF Other Details
Segment | EQ | |
Market Capital | 274202464.00 | |
Sector | Healthcare | |
Industry | Medical Devices | |
Offical website | > echo $website ; ?> |
PROF Address
PROF Latest News
PROF Business Profile
Profound Medical Corp., together with its subsidiaries, operates as a medical technology company that develops magnetic resonance guided ablation procedures for treatment of prostate disease, uterine fibroids, and palliative pain treatment in Canada, Germany, the United States, and Finland. Its lead product TULSA-PRO system used for magnetic resonance imaging scanner in hospitals and treatment facilities. The company also offers Sonalleve, a therapeutic platform for the treatment of uterine fibroids and palliative pain relief associated with metastases in bone, as well as non-invasive treatment of uterine fibroids. Profound Medical Corp. is headquartered in Mississauga, Canada. Address: 2400 Skymark Avenue, Mississauga, ON, Canada, L4W 5K5
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service